Categories: Breaking News

India Clears Two New Covid Vaccines and One Pill

New Delhi: India cleared two new Covid Vaccines and one pill today. The Health Ministry cleared CORBEVAX and COVOVAX as the two new vaccines and antiviral drug Molnupiravir after approval from Central Drugs Standard Control Organisation (CDSCO).

Making the announcement, Union Minister for Health and Family Welfare, Mansukh Mandaviya tweeted in thread giving information about the vaccines and the pill.

CORBEVAX vaccine is India’s 1st indigenously developed RBD protein sub-unit vaccine against COVID19, made by Hyderabad-based firm Biological-E. COVOVAX is a Nanoparticle Vaccine to be  manufactured by Pune-based firm Serum Institute of India.

Molnupiravir can be used only in an emergency for treatment of adult patients with COVID-19 and who have high risk of progression of the disease. Molnupiravir will be manufactured in the country by 13 companies for restricted use under emergency situation.

Bureau The News Hashtag

Share
Published by
Bureau The News Hashtag

Recent Posts

Odisha ULBs Asked to Step Up Sanitation, Safety Measures Ahead of Durga Puja

Bhubaneswar: The Housing and Urban Development Department has asked Urban Local Bodies (ULBs) across Odisha…

12 hours ago

Ekamra Walks to Launch 10th Edition on October 17 with Heritage, Nature and Food Trails

Bhubaneswar: From exploring ancient temples and the story of Odisha’s capital city to discovering local…

12 hours ago

Odisha to Prepare Lightning Safety Action Plan 2027, Roadmap for 2027–2030

Bhubaneswar: Odisha will prepare a dedicated lightning safety action plan for 2027 and a roadmap…

12 hours ago

Odisha WCD Department, Birla Global University Sign MoU to Empower ADVIKA Adolescent Girls

Bhubaneswar: The Women and Child Development (WCD) Department of the Odisha government has signed a…

13 hours ago

Similipal Tiger Reserve to Welcome Tourists from November 1

Baripada: Wildlife enthusiasts and nature lovers can return to Similipal Tiger Reserve in Odisha’s Mayurbhanj…

13 hours ago

BDA to Adjust ₹10,000 Application Fee Against Flat Cost Under Ekamra Residency Scheme

Bhubaneswar: Applicants who secure flats under the Bhubaneswar Development Authority’s (BDA) Ekamra Residency housing project…

2 days ago